A 20-Mer Peptide Derived from the Lectin Domain of SP-A2 Decreases Tumor Necrosis Factor Alpha Production during

Usir S Younis1, Hong Wei Chu2, Monica Kraft1,3,4

  • 1Department of Medicine, University of Arizona, Tucson, Arizona, USA.

Insights

Human surfactant protein-A2 (hSP-A2) genetic variants influence immune responses. Peptides derived from the 223Q variant of hSP-A2 effectively reduce inflammation during Mycoplasma pneumoniae infection.

Area of Science:

  • Pulmonary immunology
  • Molecular genetics
  • Host-pathogen interactions

Background:

  • Human surfactant protein-A2 (hSP-A2) is crucial for lung immunity, modulating pathogen clearance and inflammation.
  • A common genetic variation (Gln223Lys) in SP-A2 is linked to lung diseases like asthma and pulmonary fibrosis.
  • Previous studies indicated differential binding of SP-A2 variants to Mycoplasma, suggesting functional consequences.

Purpose of the Study:

  • To investigate the immunomodulatory effects of SP-A2 peptides based on the Gln223Lys polymorphism.
  • To determine if these peptides can regulate immune responses to live *Mycoplasma pneumoniae*.

Main Methods:

  • Generation of 20-amino acid peptides flanking the 223Q and 223K variants of hSP-A2.
  • Testing peptide efficacy in SP-A knockout mice and RAW 264.7 cells infected with *M. pneumoniae*.
  • Measurement of TNF-α mRNA and protein levels, and phosphorylation of p38 and NF-κB p65.

Main Results:

  • The 223Q-containing peptide significantly reduced TNF-α mRNA and protein levels during *M. pneumoniae* infection in both models.
  • Neither peptide affected p38 phosphorylation.
  • The 223Q-20mer peptide significantly reduced NF-κB p65 phosphorylation.

Conclusions:

  • Small peptides derived from the hSP-A2 lectin domain, particularly the 223Q variant, retain immunomodulatory activity.
  • These peptides show potential in reducing inflammatory responses, specifically TNF-α induction, during *M. pneumoniae* infection.